Develops plant-based medicines targeting various diseases, aiming to offer safer and more effective treatments with reduced side effect
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Stramsen Biotech is a clinical-stage biopharmaceutical company focused on developing plant-based medicines for a range of infectious and noninfectious diseases. Leveraging an extensive medicinal plant database, the company is advancing a pipeline of drug candidates through early-stage clinical trials.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Stramsen Biotech Management Team
Stramsen Biotech Valuations & Financials
View real-time NPM data on Stramsen Biotech stock including most recent valuation and historical share price information. Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Similar Companies
like Stramsen Biotech
Cityblock Health
Health Care
Tech-driven care provider for communities with complex needs.
Benchling
Health Care
Cloud based platform for research and development in biotechnology.
Lyra
Health Care
Digital health startup using technology to connect companies and employees to mental health providers.
Eikon Therapeutics
Health Care
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Somatus
Health Care
Integrated care for patients with or at risk of developing kidney disease.
Tonal
Health Care
Delivers AI-powered strength training with digital weights and personalized coaching.
Devoted
Health Care
Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.
FAQ
We have answers
Stramsen Biotech stock does not trade on public stock exchanges. Stramsen Biotech stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Stramsen Biotech stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Stramsen Biotech Stock does not trade on public stock exchanges. In order to sell Stramsen Biotech shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Nasdaq Private Market estimates that Stramsen Biotech price per share was $ last month. This Stramsen Biotech share value estimate (known as the NPM price) is based on market activity, publicly-sourced valuation data, and other proprietary information. With NPM Data and Intelligence premium for investors, you can get visibility into the Stramsen Biotech share price today and the factors driving Stramsen Biotech valuation estimates. Learn more about premium data here.
Read more about private company stock prices: Understanding the Bid-Ask Spread: How Buyers and Sellers Match on Price
There is no ticker symbol for Stramsen Biotech stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Stramsen Biotech stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Stramsen Biotech stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Stramsen Biotech is a private company and has not had an IPO. There is currently no Stramsen Biotech IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Stramsen Biotech IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
